It has been a while since we have looked at the role of defensive medicine, or testing and procedures generated from fear of malpractice suits, in health spending. A Research Letter published in the Journal of the American Medical Association looked at the relationship between defensive medicine and the use of three hospital services. (JAMA Int. Med. Article) Thirty-nine hospitalists were involved in the study and were asked to rate their own level of defensiveness in regard to orders they actually placed in the treatment of patients. Defensiveness was rated on a scale from zero to four and the costs of the various orders was collected. An order not at all spurred by malpractice concerns was rated zero and various levels of defensiveness were represented from 1 to 4, with 4 being a completely defensive order. The relationship between use of defensive orders and a doctor’s attitude toward malpractice was also examined. Four physicians said they had no defensive orders and 21 had at least one order they said was largely defensive. Twenty-eight percent of all orders were defensive to some degree. Physicians with more defensive orders did not have significantly more total orders or significantly more overall cost per patient than did doctors with fewer defensive orders. About 13% of total patient costs were identified as due to defensive orders. Orders which were solely due to malpractice concerns were about 2.9% of costs, primarily via additional hospital days. While the authors refer to this as a small amount of cost, even the roughly 3% number would be billions of dollars in savings a year. Fear of malpractice is a real concern, both because of probably unnecessary utilization and cost it engenders, but also because it provides cover for physicians who may want to deliver more services for economic reasons.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
Commentary
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
Commentary
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…